Vivani Medical raises $8.25M in private placement led by Chairman; extends cash runway into Q2 2026

Vivani Medical, Inc.

Issued 7,366,071 shares at $1.12 each to an entity beneficially owned by Chairman Gregg Williams.
Gross proceeds of ~$8.25M; no warrants, discounts, or placement agent fees incurred.
Funding expected to extend cash runway into Q2 2026 and accelerate NPM-139 (semaglutide) implant development.
Placement occurs over multiple closings through January 15, 2026, under Rule 506/Regulation D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.